US 10927136
Phosphorus prodrugs of pyrazolo-substituted pyrimidine sGC stimulators
granted A61PA61P1/16A61P11/00
Quick answer
US patent 10927136 (Phosphorus prodrugs of pyrazolo-substituted pyrimidine sGC stimulators) held by Cyclerion Therapeutics, Inc. expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Cyclerion Therapeutics, Inc.
- Grant date
- Tue Feb 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P1/16, A61P11/00, A61P11/06, A61P11/08